B. Metzler Seel. Sohn & Co. Ag Bio Rad Laboratories, Inc. Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $9.53 Billion
- Q4 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 1,262 shares of BIO stock, worth $329,621. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,262
Previous 1,262
-0.0%
Holding current value
$329,621
Previous $422,000
1.9%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BIO
# of Institutions
478Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$501 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$405 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$272 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$255 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$195 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.43B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...